GALWAY, IRELAND--December 27, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.S. pharmaceutical company BioMarin Pharmaceutical (NYSE:BMRN) has announced plans for a US$63 million expansion of its European manufacturing plant in Cork, Ireland.

Within this article: Details expansion of Cork-based manufacturing operation by U.S. pharmaceutical company BioMarin Pharmaceutical, goals, products, previous investment, Irish pharma sector